1. Home
  2. MBX vs RM Comparison

MBX vs RM Comparison

Compare MBX & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • RM
  • Stock Information
  • Founded
  • MBX 2018
  • RM 1987
  • Country
  • MBX United States
  • RM United States
  • Employees
  • MBX N/A
  • RM N/A
  • Industry
  • MBX
  • RM Finance: Consumer Services
  • Sector
  • MBX
  • RM Finance
  • Exchange
  • MBX NYSE
  • RM Nasdaq
  • Market Cap
  • MBX 347.9M
  • RM 343.0M
  • IPO Year
  • MBX 2024
  • RM 2012
  • Fundamental
  • Price
  • MBX $6.97
  • RM $31.35
  • Analyst Decision
  • MBX Strong Buy
  • RM Hold
  • Analyst Count
  • MBX 4
  • RM 3
  • Target Price
  • MBX $37.25
  • RM $31.50
  • AVG Volume (30 Days)
  • MBX 223.9K
  • RM 38.7K
  • Earning Date
  • MBX 03-17-2025
  • RM 04-30-2025
  • Dividend Yield
  • MBX N/A
  • RM 3.84%
  • EPS Growth
  • MBX N/A
  • RM 149.40
  • EPS
  • MBX N/A
  • RM 4.14
  • Revenue
  • MBX N/A
  • RM $569,589,000.00
  • Revenue This Year
  • MBX N/A
  • RM $14.45
  • Revenue Next Year
  • MBX N/A
  • RM $8.95
  • P/E Ratio
  • MBX N/A
  • RM $7.54
  • Revenue Growth
  • MBX N/A
  • RM 6.62
  • 52 Week Low
  • MBX $6.67
  • RM $23.72
  • 52 Week High
  • MBX $27.50
  • RM $37.52
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • RM 49.04
  • Support Level
  • MBX N/A
  • RM $29.50
  • Resistance Level
  • MBX N/A
  • RM $32.02
  • Average True Range (ATR)
  • MBX 0.00
  • RM 1.21
  • MACD
  • MBX 0.00
  • RM 0.19
  • Stochastic Oscillator
  • MBX 0.00
  • RM 75.83

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About RM Regional Management Corp.

Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.

Share on Social Networks: